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In this report, we study the binding properties of albumin in a patient with acquired Von IVillebrand's -τ n i fcj A disease. Using electrophoresis, we earlier showed that i -1 1 + k s A ' the serum of this patient does not contain free albu-, min, but a complex of myeloma immunoglobulin G kappa with albumin; this complex consists of one r represents the moles of bound ligand per mol of molecule of immunoglobulin G linked to two molemacromolecule, cules of albumin by disulfide bridges (8 figure  1A , except that barbital buffer was supplemented with 2-mercaptoethanol (10 ml/1) and samples were incubated 30 min in buffer, at room temperature, before applying to the cellulose sheet.
and consequently the binding of ligands to albumin.
To investigate this possibility, we compared the binding equilibrium of bilirubin in the blood serum of this patient with the binding data for albumin. The nonbound bilirubin was determined by oxidation with hydrogen peroxide and horseradish peroxidase 1 ), assuming that the oxidation rate was greater than the dissociation rate of the bilirubin-albumin complex (9, 10).
Materials and Methods
Albumin (3.3 mmol/1, Centre de Transfusion Sanguine de Montpellier) was diluted to a concentration of 500 μηιοΐ/ΐ in 0.1 mol/1 phosphate buffer pH 7.4. Bilirubin was dissolved in isotonic saline containing 0.1 mol/1 sodium hydroxide, then added to the patient's serum or albumin solution. Total bilirubin was measured by the Jendrassik-Michaelson-Bruckner method on an Astra™ analytical system; albumin concentration was determined by the Doumas method (11); free bilirubin by the method ofJacobsen & Wennberg (10), using horseradish peroxidase (EC 1.11.1.7). Because of the low solubility of bilirubin, and the possibility of dimerization at neutral pH (12), or self-aggregation at high concentrations, we investigated molar total bilirubin/albumin ratios only up to a value of 2.5.
In this molar ratio range, and with the known affinity of albumin for bilirubin, the molar ratio of bound bilirubin to albumin and the molar ratio of total bilirubin to albumin are very close. The intra-assay coefficients of variation are: ± 3% for total bilirubin, ± 2% for albumin and ± 4% for free bilirubin.
Case report A 63 year-old male was admitted for repeated nose-bleeding to the Centre Hospitalier de la Timone, Marseille, France. On admittance, total serum proteins were 120 g/1; albumin was 600 μιηοΐ/ΐ; cellulose acetate electrophoresis revealed the absence of albumin and the presence of an abnormal fraction in the oc 2 -globulin region ( fig. l A) . An albumin-immunoglobulin G complex was isolated on Sephacryl S-300 with a relative molecular mass of 300000 (fig. IB); after reduction with 2-mercaptoethanol this complex dissociated into immunoglobulin G and albumin ( fig. 1C) . After separation on a Sephadex G-100 column, we demonstrated that it was composed of one molecule of immunoglobulin G (Af r 150000) and two molecules of albumin (M r 69 000) (8) . Figure 2 shows that the molar ratio, total bilirubin/ albumin, plotted versus the values for free bilirubin was a curve for albumin and nearly a straight line for our patient's serum. For molar ratios approximately < 1.3, the two curves are close, indicating a similar partition of free and albumin-bound bilirubin, but above this value the concentration, of free bilirubin increases more rapidly in the presence of purified albumin than in the presence of the patient's serum.
Results
The binding values were calculated by using the following linear transformations; ') Enzyme: horseradish peroxidase (EC 1.11.1.7) free bilirubin molar ratio total bilirubin/albumin = f (free bilirubin) and the reciprocal plot free bilirubin l .molar ratio total bilirubin/album E)· to the experimental plot, but an even better graphical fit was obtained with k, = 1 · 10 7 1/mol, and 17 as the number of second-class sites ( fig. 2) .
two graphical representations giving a better estimate for intercepts on the coordinate axes (6) . The equations of curves are determined by computerized second-order non-linear least-square curve fitting and the intercepts are calculated. Based on the hypothesis of two independent classes of binding sites, and using the equations developed by Klotz & Hunston (4), we determined the presence of two sites, with the association constants: k t = 3.8 · 10 7 1/mol and k 2 = 1.2 • 10 7 1/mol for albumin. These values are in good agreement with the results reported in previous work (13 -16) . The computer-generated curve based on these values was in close agreement with the experimental plot ( fig. 2 ). It was assumed that the serum of our patient also manifested two non-interacting classes of binding sites. The total number of sites was obtained from the inverse of the ordinate intercept of the reciprocal plot. This value, 13.8, was rounded off to the nearest integer, 14. The number of classes and association constants were calculated with the same method as for albumin. For the first class of sites, ki = 1.8 - 10 7 1/mol and the number of sites in this class was ni = 1; the average value of the association constant for the 13 remaining sites was k 2 = 6.4 · 10 5 1/mol. The curve generated by computer, using these values, was close
Discussion
Albumin is a monomeric protein whose complete amino acid sequence (585 residues) is known (17) . The molecule possesses 17 disulphide bridges, a single cysteine residue in position 34 and a single tryptophanyl residue in position 214. Brown et al. (18) , on the basis of a high degree of homology between bovine and human albumin, proposed that human albumin was formed by three similar globular domains I, II and III. Each domain can be subdivided into two subdomains (A and B) mainly structured as α-helices (19) . From hydrodynamic measurements performed on bovine albumin, the molecule is depicted as an oblate ellipsoid with axes 14 nm by 4 nm (20) . Recent studies of the three-dimensional structure of albumin (21) reveal that domains are connected by non-helical segments, residues 177 to 200 between domains I and II, and residues 369 to 392 between domains II and III. For this reason, despite the high percentage of amino acid residues involved in secondary structures (48% α-helix and 15% -sheet (19)), albumin remains a flexible molecule which undergoes reversible conformational changes, particularly as a result of ligandbinding; certain conformational changes exert cooperative or antagonist effects on ligand-binding (see review (7)). Albumin can bind one molecule of bilirubin with a very high affinity and a second molecule with a lower affinity. Jacobsen (22) suggests that residues 127 -297 are involved in the first site, and that lysine residue 240 may be linked to one of the carboxylate groups of bilirubin. At the same time, Berde et al. (23) reported that the first site may be between domains I and II. Broder sen et al. (24) have calculated, by fluorescence quenching, that the first bound bilirubin molecule is located 2.2 nm from the tryptophan residue; this distance is comparable with the value of 2.7 nm reported by Berde et al. (23) . For the second fixation-site, the results are conflicting. The observations of Gitzelmann et al. (25) suggest that the second molecule of bilirubin is located in the region of amino acids 446 -547 (domain HI) at 2.4 nm from tryptophan 214. On the other hand, Brodersen et al. (24) established that the second molecule of bilirubin is closely bound with the first, at a distance of 1.8 nm from tryptophan. The different association constant and different number of binding sites for human serum albumin and the serum of our patient clearly indicate that complex formation between albumin and immunoglobulin modifies the binding isotherms of bilirubin (fig. 2) . The fact that all the albumin is linked ( fig. 1A ) and that its primary structure is normal (indeed, the complex with myeloma immunoglobulin appears in vivo after plasmapheresis, as well as in vitro with normal human albumin) indicates that the differences observed reflect the resulting conformational changes of bound albumin. The serum of our patient contains one binding site with an affinity (k^ = 1 · 10 7 -1.8 • 10 7 1/mol) intermediate between the two values determined for albumin (k, = 3.8 · 10 7 1/mol, k 2 = 1.2 • 10 7 1/mol); our results also indicate that the secondary site is no longer operative, and that 13 to 17 sites with 30-fold weaker affinity (k 2 = 6.4 · 10 5 1/mol) are present. The linkage of albumin to immunoglobulin by an S-S bond, probably derived from the sulphydryl of cysteine 34 whose reactivity is distinctive at this pH (20) , can be expected to induce perturbations in the intramolecular interactions of domain I, where this cysteinyl residue is located. Although domain I does not contribute to the binding mechanism of bilirubin, our data suggest that one of the two highaffinity sites is dramatically affected by the coupling with immunoglobulin G.
Bilirubin can interact with other sites in serum such as αϊ-and qc 2 -globulins (26, 27) , but with one hundred to one thousand-fold less binding strength than the high-affinity site of albumin (27). It is clear that the existence of 14 to 18 total binding sites, determined in the serum of our patient, should not be attributed solely to albumin but also to other plasma proteins. Since the results obtained from healthy subjects do not display such differences compared with pure albumin solutions (data not shown), the results observed are certainly due to the high concentration of immunoglobulin G. In order to understand the perturbations induced, firstly by the association of albumin with immunoglobulin G, and secondly, by the abnormally high concentration of a protein other than albumin, we plan to study the binding characteristics of other ligands in the serum of our patient and of other patients with hypergammaglobulinaemia.
